FTH Faeth Therapeutics, Inc. stock chart & analysis

Conviction 40HealthcareScan · Fri, Nov 6, 2026

Faeth Therapeutics, Inc. (FTH) closed at $22.01 (+10.47%) on Nov 6, 2026. Price is below its 50-day. RSI(14) 50, -47.8% from its 52-week high, +51.4% year to date. Sector: Healthcare.

FTH$22.01+10.47%

ResistanceSupportVol 14

Loading chart…

Faeth Therapeutics, Inc.

Price22.01

Change+10.47%

Gap+1.41%

Rel volume1.76×

Avg volume386.46K

Avg $ vol7.64M

SMA 2019.78

SMA 5027.46

SMA 200—

Price vs 50-19.86%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 24.52

RSI (14)50

MACD hist0.69

MACD crossbull · 6d

Stoch %K / %D100 / 75

ADX (14)25

+DI / −DI22 / 22

RSI divergence—

MACD divergence—

ATR %9.76%

ADR %10.43%

52w high42.14

52w low13.43

From 52w high-47.79%

Above 52w low+63.85%

New 52w highNo

SqueezeOff

Bollinger width29.64%

%B0.88

Donchian pos57.64%

Donchian high26.00

Donchian low16.57

AVWAP (52w high)27.02

vs AVWAP high-18.56%

AVWAP (52w low)28.29

vs AVWAP low-22.23%

OBV trendFlat

Chaikin MF (20)-0.12

Today vs 20d1.76×

Avg vol (14d)390.67K

Avg vol (20d)386.46K

Avg $ vol (20d)7.64M

Market cap568.7M

RS Rating—

RS 3m (vs SPY)-18.11%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank34.8

1 week+17.74%

1 month-14.08%

3 months-22.98%

6 months—

1 year—

YTD+51.45%

P/E-26.97

P/B3.53

P/S—

P/FCF-27.78

EPS-16.72

Div yield—

ROE-13.09%

ROA-11.78%

Debt/Eq0.00

Current16.12

EV/EBITDA-25.04

Gross margin—

Net margin—

Rev growth—

EPS growth30.08%

Price target57.22

Target upside160.03%

Analyst ratingBuy

Institutional56.64%

Ent. value555.08M

Revenue—

Net income-20.4M

Gross profit—

Free cash flow-20.47M

Industry—

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float322.65K

Float %1.2%

Short interest—

Days to cover—

Short volume43.8%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est−$0.79 vs −$0.66

Last surprise-19.7% miss

Setup gradeD

Conviction40 / 100

Pattern quality—

Tech rank34.8 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance30.39

Support17.23

Days since event—

Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

FTH technical analysis

Trend

It closed 19.9% below the 50-day ($27.46). ADX(14) at 25 points to a moderate trend.

Momentum

RSI(14) is 50, in the bearish half of its range. MACD crossed above its signal line 6 sessions ago.

Volume and volatility

Volume on the latest session ran 1.8× its 20-day average. It trades about $7.6M a day on average. ATR(14) is $2.15, 9.8% of price — its typical daily range. Chaikin Money Flow (-0.12) shows distribution.

Key levels

The chart pattern's support is $17.23 and its resistance $30.39. The 52-week range is $13.43 to $42.14; price is 47.8% below the high and 63.8% above the low. The VWAP anchored at the 52-week high is $27.02, above price.

Performance

FTH returned +17.7% (1 week), -14.1% (1 month), -23.0% (3 months), +51.4% (year to date).

Insider activity

SEC Form 4 transactions in FTH

Insider	Side	Shares	Value	Traded	Filed
Parikh Anand Kiran President and CEO · Common Stock · 2026-10-30	Gift	100K	—	2026-10-30	2026-11-03
Parikh Anand Kiran President and CEO · Common Stock · 2026-10-30	Gift	100K	—	2026-10-30	2026-11-03
Schayowitz Adam Director · Stock Option (right to buy) · 2026-10-23	Grant	25K	—	2026-10-23	2026-10-27
Vousden Karen H Director · Stock Option (right to buy) · 2026-09-11	Grant	25K	—	2026-09-11	2026-09-15

SEC filings

EDGAR filings in FTH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.